Clinical characteristics of 82 death cases with COVID-19
Bicheng Zhang(University of Electronic Science and Technology of China), Jun Wang(Shenzhen Bao'an District People's Hospital), Lilei Yu(Wuhan University), Zhixin Huang(Wuhan University), Yifan Jia(Sun Yat-sen University), Biheng Cheng(Wuhan University), Xiaoyang Zhou(China Mobile (China)), Hongping Deng(Wuhan University), Yanru Qiu(Jiangnan University), Yanxiang Cheng(Wuhan University), Ling Gao(Wuhan University), Ke Hu(Capital Normal University), Zaiming Liu(Wuhan University), Zhangfan Mao(Wuhan University), Yijun Ren(Wuhan University), Ting Zhu(National Clinical Research Center for Digestive Diseases), Zhichao Liu(Wuhan University), Yiping Gong(Wuhan University), Bo Zhu(Dalian Medical University), Jia Feng(Wuhan University), Xiongfei Wu(Wuhan University), Fan Feng(Wuhan University), Shihong Wang(City University of Hong Kong), Chenliang Zhou(Wuhan University), Hengcheng Zhu(Wuhan University), Fenghua Tao(Wuhan University), Qibin Song(Wuhan University), Jiasheng Liu(Wuhan University)
Cited by 249
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
|New England Journal of Medicine|2021|742
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497
Prognostic Value of C-Reactive Protein in Patients With Coronavirus 2019
|Clinical Infectious Diseases|2020|458